289 related articles for article (PubMed ID: 32653467)
41. Who will benefit from DNase?
Rubin BK
Pediatr Pulmonol; 1999 Jan; 27(1):3-4. PubMed ID: 10023784
[No Abstract] [Full Text] [Related]
42. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
Bates RD; Nahata MC
J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
[TBL] [Abstract][Full Text] [Related]
43. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
44. The clinical use of rhDNAse.
Davies J; Trindale M; Wallis C; Rosenthal M; Bush A
Pediatr Pulmonol Suppl; 1997; 16():273-4. PubMed ID: 9443309
[No Abstract] [Full Text] [Related]
45. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
[TBL] [Abstract][Full Text] [Related]
46. Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice.
Terlizzi V; Masi E; Francalanci M; Taccetti G; Innocenti D
Ital J Pediatr; 2021 Aug; 47(1):168. PubMed ID: 34362426
[TBL] [Abstract][Full Text] [Related]
47. Dornase alfa therapy in cystic fibrosis: who should get it?
Kanga JF
Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
[No Abstract] [Full Text] [Related]
48. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
Kling S; Gie RP; Riphagen S
Pediatr Pulmonol; 1997 Aug; 24(2):124-5. PubMed ID: 9292906
[No Abstract] [Full Text] [Related]
49. Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis.
Athanazio R; da Costa JC; de la Rosa Carrillo D; Martínez-García MÁ
Expert Rev Respir Med; 2018 Jul; 12(7):569-584. PubMed ID: 29806511
[TBL] [Abstract][Full Text] [Related]
50. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
Derelle J; Bertolo-Houriez E; Marchal F; Weber M; Virion JM; Vidailhet M
Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
[TBL] [Abstract][Full Text] [Related]
51. Trends in the use of routine therapies in cystic fibrosis: 1995-2005.
Konstan MW; VanDevanter DR; Rasouliyan L; Pasta DJ; Yegin A; Morgan WJ; Wagener JS; ;
Pediatr Pulmonol; 2010 Dec; 45(12):1167-72. PubMed ID: 20717935
[TBL] [Abstract][Full Text] [Related]
52. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
McCoy K; Hamilton S; Johnson C
Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
[TBL] [Abstract][Full Text] [Related]
53. Dornase alpha and survival of patients with cystic fibrosis.
McIntyre AM
Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
[TBL] [Abstract][Full Text] [Related]
54. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
Suri R
BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
[TBL] [Abstract][Full Text] [Related]
55. Adjunctive therapy in cystic firbrosis (CF).
Voter KZ
Pediatr Infect Dis J; 1998 Apr; 17(4):341-2. PubMed ID: 9576391
[No Abstract] [Full Text] [Related]
56. [Recombinant human DNase in conditions other than cystic fibrosis].
Kristensen K
Ugeskr Laeger; 2010 Feb; 172(8):616-9. PubMed ID: 20184817
[TBL] [Abstract][Full Text] [Related]
57. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
58. Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
Johnson CA; Butler SM; Konstan MW; Breen TJ; Morgan WJ
J Pediatr; 1999 Jun; 134(6):734-9. PubMed ID: 10356143
[TBL] [Abstract][Full Text] [Related]
59. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
Hurt K; Bilton D
Respiration; 2014; 88(6):441-8. PubMed ID: 25472021
[TBL] [Abstract][Full Text] [Related]
60. Mucolytics, expectorants, and mucokinetic medications.
Rubin BK
Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
